{"transactions":[{"id":828139,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Warrant (right to buy)","published_at":"2026-03-26T01:18:27.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":false,"shares":47333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2026-04-17","underlying":"Common Stock","underlying_shares":47333},"source":{"system":"sec-edgar","filing":"0001256153-26-000004","document":"form4-03262026_010323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615326000004/form4-03262026_010323.xml","form_type":"4"}},{"id":828138,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-03-26T01:18:27.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":47333,"price":1.4,"value":66266.2,"ownership":{"direct":true},"balance_after":3735048,"source":{"system":"sec-edgar","filing":"0001256153-26-000004","document":"form4-03262026_010323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615326000004/form4-03262026_010323.xml","form_type":"4"}},{"id":873719,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-02T21:30:17.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":957000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2026, subject to the Reporting Person's continued services through each such date."}],"balance_after":957000,"derivative":{"exercise_price":1.65,"expiration_date":"2036-02-25","underlying":"Common Stock","underlying_shares":957000},"source":{"system":"sec-edgar","filing":"0001256153-26-000002","document":"form4-03022026_040301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615326000002/form4-03022026_040301.xml","form_type":"4"}},{"id":962960,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-12-18T21:15:07.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":71,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001256153-25-000004","document":"form4-12182025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615325000004/form4-12182025_041203.xml","form_type":"4"}},{"id":962959,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Series B Warrant (right to buy)","published_at":"2025-12-18T21:15:07.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":35500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Series B Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025."}],"balance_after":35500,"derivative":{"exercise_price":1.4,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001256153-25-000004","document":"form4-12182025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615325000004/form4-12182025_041203.xml","form_type":"4"}},{"id":962958,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Series A Warrant (right to buy)","published_at":"2025-12-18T21:15:07.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":47333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Warrants will terminate upon the earlier of (a) the 30th calendar day following date on which we publicly announce the clearance of the first of any investigational new drug application, clinical trial application or other foreign equivalent with respect to the clinical development of our OV4071 product candidate; provided that such 30-calendar day period shall not commence unless and until a registration statement covering the resale of the shares of Common Stock issuable upon exercise of the Series A Warrants is effective; and (b) October 6, 2030."}],"balance_after":47333,"derivative":{"exercise_price":1.4,"underlying":"Common Stock","underlying_shares":47333},"source":{"system":"sec-edgar","filing":"0001256153-25-000004","document":"form4-12182025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615325000004/form4-12182025_041203.xml","form_type":"4"}},{"id":962957,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-12-18T21:15:07.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":71,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."}],"balance_after":71,"derivative":{"underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001256153-25-000004","document":"form4-12182025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615325000004/form4-12182025_041203.xml","form_type":"4"}},{"id":962956,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-18T21:15:07.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":71000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025."}],"balance_after":3687715,"source":{"system":"sec-edgar","filing":"0001256153-25-000004","document":"form4-12182025_041203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000125615325000004/form4-12182025_041203.xml","form_type":"4"}},{"id":1249211,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-25T00:55:09.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2025, subject to the Reporting Person's continued services through each such date."}],"balance_after":1650000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001415889-25-005368","document":"form4-02242025_070206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000141588925005368/form4-02242025_070206.xml","form_type":"4"}},{"id":1565793,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-20T21:22:00.000Z","date":"2024-03-18","kind":"purchase","planned":false,"acquired":true,"shares":18248,"price":2.76,"value":50364.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.76 to $2.78 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":3616715,"source":{"system":"sec-edgar","filing":"0001209191-24-005001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919124005001/doc4.xml","form_type":"4"}},{"id":1618939,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T22:58:39.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date."}],"balance_after":700000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-24-003964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919124003964/doc4.xml","form_type":"4"}},{"id":1642777,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-14T21:15:21.000Z","date":"2019-09-20","kind":"gift","planned":false,"acquired":false,"shares":465116,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were transferred to two family trusts for the benefit of the Reporting Person's adult children as part of generational estate planning. These transfers were made for no consideration. The Reporting Person does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares.  These transactions are being reported late due to an inadvertent administrative error."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Prior to the gift, the reportable securities were owned directly by DSL-EAL Holdings LLC (the \"LLC\"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-003721","document":"form4a-02142024_040202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000141588924003721/form4a-02142024_040202.xml","form_type":"4/A","original_submission_date":"2019-10-10"}},{"id":1719932,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-12-06T22:05:47.000Z","date":"2023-12-04","kind":"gift","planned":false,"acquired":false,"shares":573275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The\nreporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor\ndoes he maintain investment control over, or have a pecuniary interest in, the shares."}],"balance_after":3598467,"source":{"system":"sec-edgar","filing":"0001209191-23-057640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919123057640/doc4.xml","form_type":"4"}},{"id":1719931,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-12-06T22:05:47.000Z","date":"2023-12-04","kind":"gift","planned":false,"acquired":false,"shares":573275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The\nreporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor\ndoes he maintain investment control over, or have a pecuniary interest in, the shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This direct ownership total corrects an inadvertent administrative error in the number of shares of common stock that were reported as directly held on the Form 4 filed by the reporting executive on September 1, 2020. Before the transactions reported herein, the reporting executive held 4,745,017 shares of common stock directly"}],"balance_after":4171742,"source":{"system":"sec-edgar","filing":"0001209191-23-057640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919123057640/doc4.xml","form_type":"4"}},{"id":1989904,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T21:58:29.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":600000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-23-013236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919123013236/doc4.xml","form_type":"4"}},{"id":2298274,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:36:41.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":423244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":423244,"derivative":{"exercise_price":3.22,"expiration_date":"2032-04-07","underlying":"Common Stock","underlying_shares":423244},"source":{"system":"sec-edgar","filing":"0001209191-22-024189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919122024189/doc4.xml","form_type":"4"}},{"id":2411476,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T23:14:17.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":600000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-22-007305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919122007305/doc4.xml","form_type":"4"}},{"id":2935950,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-21T21:45:03.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":650000,"derivative":{"exercise_price":2.82,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001209191-20-064657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919120064657/doc4.xml","form_type":"4"}},{"id":3042408,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-09-02T01:34:16.000Z","date":"2020-08-28","kind":"purchase","acquired":true,"shares":8488,"price":5.84,"value":49569.92,"ownership":{"direct":true},"balance_after":5792530,"source":{"system":"sec-edgar","filing":"0001209191-20-049011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919120049011/doc4.xml","form_type":"4"}},{"id":3333704,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-20T21:24:36.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":600000,"derivative":{"exercise_price":4.42,"expiration_date":"2029-12-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-19-061560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919119061560/doc4.xml","form_type":"4"}},{"id":3394643,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-10-11T00:32:29.000Z","date":"2019-10-08","kind":"purchase","acquired":true,"shares":60000,"price":2.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were purchased in a Public Offering of the Issuer at a public offering price of $2.50."}],"balance_after":4736529,"source":{"system":"sec-edgar","filing":"0001209191-19-052988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919119052988/doc4.xml","form_type":"4"}},{"id":3631494,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-27T02:42:59.000Z","date":"2019-02-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":250000,"derivative":{"exercise_price":1.89,"expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-19-013905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919119013905/doc4.xml","form_type":"4"}},{"id":3631493,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-02-27T02:42:59.000Z","date":"2019-02-22","kind":"purchase","acquired":true,"shares":75000,"price":2,"value":150000.0,"ownership":{"direct":true},"balance_after":4676529,"source":{"system":"sec-edgar","filing":"0001209191-19-013905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919119013905/doc4.xml","form_type":"4"}},{"id":4092212,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-23T21:41:55.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date."}],"balance_after":290000,"derivative":{"exercise_price":9.18,"expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001209191-18-004911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919118004911/doc4.xml","form_type":"4"}},{"id":4223383,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-08-28T22:29:16.000Z","date":"2017-08-25","kind":"purchase","acquired":true,"shares":15334,"price":7.15,"value":109638.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $6.65 to $7.33 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote."}],"balance_after":4601529,"source":{"system":"sec-edgar","filing":"0001209191-17-050467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919117050467/doc4.xml","form_type":"4"}},{"id":4326426,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Series B Preferred Stock","published_at":"2017-05-10T21:16:21.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":35461,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by Divo Holdings, LLC (\"Divo\"). The Reporting Person's spouse in the manager of Divo. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35461},"source":{"system":"sec-edgar","filing":"0001209191-17-031376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919117031376/doc4.xml","form_type":"4"}},{"id":4326425,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Series A Preferred Stock","published_at":"2017-05-10T21:16:21.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":400150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400150},"source":{"system":"sec-edgar","filing":"0001209191-17-031376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919117031376/doc4.xml","form_type":"4"}},{"id":4326424,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-05-10T21:16:21.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":35461,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by Divo Holdings, LLC (\"Divo\"). The Reporting Person's spouse in the manager of Divo. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose."}],"balance_after":35461,"source":{"system":"sec-edgar","filing":"0001209191-17-031376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919117031376/doc4.xml","form_type":"4"}},{"id":4326423,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-05-10T21:16:21.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":400150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock and Series B Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."}],"balance_after":4586195,"source":{"system":"sec-edgar","filing":"0001209191-17-031376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256153/000120919117031376/doc4.xml","form_type":"4"}},{"id":500571,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Restricted Stock Units","published_at":"2011-10-05T00:29:11.000Z","date":"2011-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converted into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"10,000 shares vested on October 1, 2011."}],"balance_after":0,"derivative":{"expiration_date":"2011-10-01","underlying":"Common Stock, $0.10 par value","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001225208-11-022950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811022950/doc4.xml","form_type":"4"}},{"id":500570,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-10-05T00:29:11.000Z","date":"2011-10-01","kind":"tax_withholding","acquired":false,"shares":4704,"price":31.38,"value":147611.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock units."}],"balance_after":43689,"source":{"system":"sec-edgar","filing":"0001225208-11-022950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811022950/doc4.xml","form_type":"4"}},{"id":500569,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-10-05T00:29:11.000Z","date":"2011-10-01","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48393,"source":{"system":"sec-edgar","filing":"0001225208-11-022950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811022950/doc4.xml","form_type":"4"}},{"id":506335,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-16T20:31:54.000Z","date":"2011-03-01","kind":"tax_withholding","acquired":false,"shares":2916,"price":25.58,"value":74591.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon payout of the 2008-2010 special long-term performance award."}],"balance_after":34938,"source":{"system":"sec-edgar","filing":"0001225208-11-009853","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811009853/doc4a.xml","form_type":"4/A","original_submission_date":"2011-03-03"}},{"id":506334,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-16T20:31:54.000Z","date":"2011-03-01","kind":"tax_withholding","acquired":false,"shares":2324,"price":25.58,"value":59447.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award."}],"balance_after":37854,"source":{"system":"sec-edgar","filing":"0001225208-11-009853","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811009853/doc4a.xml","form_type":"4/A","original_submission_date":"2011-03-03"}},{"id":506714,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Restricted Stock Units","published_at":"2011-03-08T22:22:48.000Z","date":"2011-03-04","kind":"exercise","acquired":false,"shares":1397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock."}],"balance_after":1397,"derivative":{"expiration_date":"2012-03-04","underlying":"Common Stock, $0.10 par value","underlying_shares":1397},"source":{"system":"sec-edgar","filing":"0001225208-11-009158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811009158/doc4.xml","form_type":"4"}},{"id":506713,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-08T22:22:48.000Z","date":"2011-03-04","kind":"tax_withholding","acquired":false,"shares":566,"price":26.43,"value":14959.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock units."}],"balance_after":38393,"source":{"system":"sec-edgar","filing":"0001225208-11-009158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811009158/doc4.xml","form_type":"4"}},{"id":506712,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-08T22:22:48.000Z","date":"2011-03-04","kind":"exercise","acquired":true,"shares":1397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired upon vesting of restricted stock units."}],"balance_after":38959,"source":{"system":"sec-edgar","filing":"0001225208-11-009158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811009158/doc4.xml","form_type":"4"}},{"id":506848,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Restricted Stock Units","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-03","kind":"exercise","acquired":false,"shares":2019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Twenty-five percent of the restricted stock units will vest on each of the first, second, third and fourth anniversaries of the grant date and be converted into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Twenty-five percent of the restricted stock units will vest on each of the first, second, third and fourth anniversaries of the grant date and be converted into shares of common stock."}],"balance_after":4039,"derivative":{"expiration_date":"2013-03-03","underlying":"Common Stock, $0.10 par value","underlying_shares":2019},"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506847,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Market Share Units","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-02","kind":"exercise","acquired":false,"shares":2307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor."}],"balance_after":18233,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":2307},"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506846,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-03","kind":"tax_withholding","acquired":false,"shares":818,"price":26.14,"value":21382.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld for payment of taxes upon vesting of restricted stock units."}],"balance_after":37562,"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506845,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-03","kind":"exercise","acquired":true,"shares":2019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares acquired upon vesting of resticted share units."}],"balance_after":38380,"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506844,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-02","kind":"tax_withholding","acquired":false,"shares":968,"price":25.39,"value":24577.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon vesting of market share units."}],"balance_after":36361,"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506843,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-02","kind":"other","acquired":true,"shares":84,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor."}],"balance_after":37329,"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506842,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-05T02:20:41.000Z","date":"2011-03-02","kind":"exercise","acquired":true,"shares":2307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired upon vesting of market share units."}],"balance_after":37245,"source":{"system":"sec-edgar","filing":"0001225208-11-008911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008911/doc4.xml","form_type":"4"}},{"id":506985,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"exercise","acquired":false,"shares":9046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."}],"balance_after":0,"derivative":{"expiration_date":"2011-03-31","underlying":"Common Stock, $0.10 par value","underlying_shares":9046},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506984,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"exercise","acquired":false,"shares":3898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."}],"balance_after":8479.86,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3898},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506983,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"other","acquired":true,"shares":281.86,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013."},{"field":"shares","element":"transactionShares","label":"F12","text":"Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013."}],"balance_after":12377.86,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":281.86},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506982,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"grant","acquired":true,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2012."},{"field":"shares","element":"transactionShares","label":"F11","text":"Consists of performance shares earned under the 2009-2011 Long-Term Performance Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2012."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2012."}],"balance_after":12096,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":2682},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506981,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"grant","acquired":true,"shares":3898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2011."}],"balance_after":9414,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3898},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506980,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Performance Shares","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"grant","acquired":true,"shares":5516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2013."},{"field":"shares","element":"transactionShares","label":"F8","text":"Consists of performance shares earned under the 2010-2012 Long-Term Performance Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2013."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2013."}],"balance_after":5516,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":5516},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506979,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Market Share Units","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"grant","acquired":true,"shares":11312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor."}],"balance_after":20540,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":11312},"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506978,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"tax_withholding","acquired":false,"shares":2916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld for payment of taxes upon payout of the 2008-2010 special long-term performance award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend reinvestment shares."}],"balance_after":34938,"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506977,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"tax_withholding","acquired":false,"shares":2324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend reinvestment shares."}],"balance_after":37854,"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":506976,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2011-03-04T02:58:18.000Z","date":"2011-03-01","kind":"exercise","acquired":true,"shares":12944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend reinvestment shares."}],"balance_after":40178,"source":{"system":"sec-edgar","filing":"0001225208-11-008706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520811008706/doc4.xml","form_type":"4"}},{"id":514462,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Restricted Stock Units","published_at":"2010-10-05T20:59:07.000Z","date":"2010-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"10,000 shares will vest on each of October 1, 2010 and October 1, 2011.   Each restricted stock unit will be converted into one share of common stock upon vesting."}],"balance_after":10000,"derivative":{"expiration_date":"2011-10-01","underlying":"Common Stock, $0.10 par value","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001225208-10-022271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520810022271/doc4.xml","form_type":"4"}},{"id":514461,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2010-10-05T20:59:07.000Z","date":"2010-10-01","kind":"tax_withholding","acquired":false,"shares":4148,"price":27.28,"value":113157.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for payment of taxes upon vesting of restricted stock units."}],"balance_after":26357,"source":{"system":"sec-edgar","filing":"0001225208-10-022271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520810022271/doc4.xml","form_type":"4"}},{"id":514460,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":16837,"kind":"person","name":"LEVIN JEREMY M","position":1,"cik":"0001256153","reported_name":"LEVIN JEREMY M","relationship":{"officer":true,"officer_title":"SVP Strat Transactions"}}],"security":"Common Stock, $0.10 par value","published_at":"2010-10-05T20:59:07.000Z","date":"2010-10-01","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30505,"source":{"system":"sec-edgar","filing":"0001225208-10-022271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000122520810022271/doc4.xml","form_type":"4"}}]}